Clinical Trial Update: Study to Evaluate the Safety and Efficacy of Pegvaliase in Adolescents (Ages 12-17) With Phenylketonuria [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating pegvaliase for phenylketonuria in adolescents (ages 12-17) is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Phenylketonuria

Drugs mentioned

• Pegvaliase (pegvaliase)

Snippet

Sponsor: BioMarin Pharmaceutical | Conditions: Phenylketonuria (PKU) | Phase 3 | Status: ACTIVE_NOT_RECRUITING